Trials / Conditions / Human Metapneumovirus
Human Metapneumovirus
5 registered clinical trials studyying Human Metapneumovirus.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vacc NCT06546423 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate NCT06134648 | Sanofi Pasteur, a Sanofi Company | Phase 1 / Phase 2 |
| Active Not Recruiting | A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to < NCT05743881 | ModernaTX, Inc. | Phase 1 |
| Completed | Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults NCT01109329 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Unknown | Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses NCT00613184 | Kern Medical Center | N/A |